NEW YORK (GenomeWeb News) – When Nicholas Navin's R01 grant to use single-cell sequencing to study tumor evolution in breast cancer was first funded in 2012, it was funded at 83 percent of the requested budget.
Because of the sequester, Navin's grant now will be cut a further 6 percent. In addition, he has only been given funding for the next three months.